The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

General Cancer Screen 9 Tissue Microarray - LS-SCA9

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SCA9
Product Name:	General Cancer Screen 9
Description:	Multiple cancer types with stage/grade and clinical data, and a single normal specimen for each of 6 tissue types: Colon, Esophagus, Kidney, Liver, Rectum, and Stomach
Format:	FFPE
Category:	Human Multi-Tumor and Normal
QA/QC:	H&E reviewed
Storage:	Short term RT; Long term 4ºC
Clinical History:	Yes
Tissue Marker:	No
Stage/Grade:	Yes
Core Diameter:	1.5 mm
Core Thickness:	5-6 µm
Cases:	65
Cores:	65
Slides Per Set:	1

LS-SCA9 Tissue Microarray Map

Slide Number 1

LABEL

	1	2	3	4	5	6	7	8	9	10	11
A	Pla		Kid	Kid	Kid	Kid	Kid	Kid	Kid	Kid	Kid
B	Col	Col	Col	Col	Col	Col	Col	Col	Col	Col	Col
C	Eso	Eso	Eso	Eso	Eso	Eso	Eso	Eso	Eso	Eso	Eso
D	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv	Liv
E	Rec	Rec	Rec	Rec	Rec	Rec	Rec	Rec	Rec	Rec	Rec
F	Sto	Sto	Sto	Sto	Sto	Sto	Sto	Sto	Sto	Sto	Sto

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Colon (Col); Colon, Sigmoid (Col); Esophagus (Eso); Kidney (Kid); Liver (Liv); Placenta (Pla); Rectum (Rec); Stomach (Sto);

LS-SCA9 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type	TNM Tumor Classification	Tumor Differentiation	Tumor History	Tumor Size
1	A1	Human	F	29 y	Placenta (Pla)	Normal	Benign non-neoplastic
1	A3	Human	M	53 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N0M0	Moderately	30 Days	4.5x4x4 cm
1	A4	Human	M	54 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N0M0	Moderately	30 Days	3x3x2.5 cm
1	A5	Human	M	50 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N0M0	Poorly-Moderately	20 Days	4x3x3 cm
1	A6	Human	M	70 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T3N0M0	Moderately	15 Days	6x5x5 cm
1	A7	Human	M	50 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T2N0M0	Well	40 Days	3.5x3.5x3.2 cm
1	A8	Human	M	60 y	Kidney (Kid)	Transitional cell carcinoma	Malignant	T3N0M0	Moderately	1 Month	6x4x2.5 cm
1	A9	Human	M	60 y	Kidney (Kid)	Matched adjacent normal	Benign non-neoplastic
1	A10	Human	M	47 y	Kidney (Kid)	Clear cell carcinoma	Malignant	T3N0M0	Moderately	20 Days	5x5x4.5 cm
1	A11	Human	M	47 y	Kidney (Kid)	Matched adjacent normal	Benign non-neoplastic
1	B1	Human	M	68 y	Colon, Sigmoid (Col)	Adenocarcinoma, Ulcer	Malignant	T3N2M0	Moderately	3 Months	5x4x2 cm
1	B2	Human	M	75 y	Colon (Col)	Metastasis from greater omentum adenocarcinoma	Metastatic	TxN2M1	Moderately	3 Years
1	B3	Human	M	54 y	Colon (Col)	Adenocarcinoma	Malignant	T3N1M0	Moderately	1 Month	5x4x4 cm
1	B4	Human	F	22 y	Colon (Col)	Mesenchymoma	Tumor	T3N0M0	Well	15 Days	Diameter 8 cm
1	B5	Human	F	42 y	Colon, Sigmoid (Col)	Adenocarcinoma	Malignant	T2N0M0	Well	32 Days	4.2x3.5x2.7 cm
1	B6	Human	M	65 y	Colon (Col)	Adenocarcinoma	Malignant	T2N0M1	Poorly	2 Months	3x2.5x1.2 cm
1	B7	Human	M	61 y	Colon (Col)	Adenocarcinoma	Malignant	T3N2M1	Moderately-Well	20 Days	6x4x2.5 cm
1	B8	Human	M	63 y	Colon (Col)	Adenocarcinoma	Malignant	T2N1M0	Moderately	2 Months	Diameter 2.5 cm
1	B9	Human	M	63 y	Colon (Col)	Matched adjacent normal	Benign non-neoplastic
1	B10	Human	F	71 y	Colon (Col)	Adenocarcinoma	Malignant	T2N0M0	Moderately	4 Months	4x4x4 cm
1	B11	Human	F	71 y	Colon (Col)	Matched adjacent normal	Benign non-neoplastic
1	C1	Human	M	57 y	Esophagus (Eso)	Squamous cell carcinoma with ulcer	Malignant	T3N3M0	Moderately	2 Months	5x4x0.5 cm
1	C2	Human	M	59 y	Esophagus (Eso)	Small cell carcinoma	Malignant	T2N1M0	Poorly	6 Months	2.5x2 cm
1	C3	Human	M	70 y	Esophagus (Eso)	Squamous cell carcinoma	Malignant		Moderately	7 Days	5x3.5 cm
1	C4	Human	M	67 y	Esophagus (Eso)	Squamous cell carcinoma	Malignant	T2N0M0	Moderately	40 Days	4x3x3 cm
1	C5	Human	M	71 y	Esophagus (Eso)	Squamous cell carcinoma	Malignant	T2N2M0	Poorly	1.5 Months	4x3.5x3 cm
1	C6	Human	M	51 y	Esophagus (Eso)	Squamous cell carcinoma	Malignant	T2N0M0	Poorly-Moderately	2 Months	4.5x4x3 cm
1	C7	Human	M	72 y	Esophagus (Eso)	Squamous cell carcinoma with ulcer, non-cornifying	Malignant	T3N2M0	Poorly	5 Months	7x5x5 cm
1	C8	Human	F	70 y	Esophagus (Eso)	Squamous cell carcinoma	Malignant	T2N0M0	Well	5 Months	2x2 cm
1	C9	Human	F	70 y	Esophagus (Eso)	Matched adjacent normal	Benign non-neoplastic
1	C10	Human	M	52 y	Esophagus (Eso)	Small cell carcinoma with ulcer	Malignant	T3N2M1	Poorly	2 Months	6X3X1.5 cm
1	C11	Human	M	52 y	Esophagus (Eso)	Matched adjacent normal	Benign non-neoplastic
1	D1	Human	F	47 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0		1 Year	4x3 cm
1	D2	Human	M	58 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	Poorly-Moderately	40 Days	5x5x4 cm
1	D3	Human	M	59 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	Moderately	40 Days	4x3x3 cm
1	D4	Human	M	50 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	Moderately	1.5 Months	3.5x3x3 cm
1	D5	Human	M	60 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0	Moderately	1 Year	3.5x3.5x3 cm
1	D6	Human	M	51 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0	Moderately	10 Months	10x8x4 cm
1	D7	Human	M	54 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T2N0M0		15 Days	4x3x3 cm
1	D8	Human	M	56 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N2M1	Poorly	2 Months	10x8x6 cm
1	D9	Human	M	56 y	Liver (Liv)	Matched adjacent normal	Benign non-neoplastic
1	D10	Human	M	65 y	Liver (Liv)	Hepatocellular carcinoma	Malignant	T3N0M0		2 Months	6x5x4 cm
1	D11	Human	M	65 y	Liver (Liv)	Matched adjacent normal	Benign non-neoplastic
1	E1	Human	F	46 y	Rectum (Rec)	Adenocarcinoma	Malignant	T2N0M0	Poorly	1.5 Months	5.5x5x3 cm
1	E2	Human	F	54 y	Rectum (Rec)	Adenocarcinoma	Malignant	T3N1M1	Moderately	3 Months	6x5x3 cm
1	E3	Human	M	43 y	Rectum (Rec)	Adenocarcinoma	Malignant	T2N1M0	Moderately	1 Month	4x4x3 cm
1	E4	Human	F	50 y	Rectum (Rec)	Adenocarcinoma, Ulcer	Malignant	T3N3M0	Well	4 Months	5x7 cm
1	E5	Human	F	62 y	Rectum (Rec)	Adenocarcinoma	Malignant	T3N2M0	Moderately	3 Months	Diameter 6 cm
1	E6	Human	F	51 y	Rectum (Rec)	Adenocarcinoma, Ulcer	Malignant	T3N1M0	Moderately	2 Months	Diameter 5 cm
1	E7	Human	M	66 y	Rectum (Rec)	Adenocarcinoma, Ulcer	Malignant	T3N1M0	Moderately	3 Months	6.5x6x3 cm
1	E8	Human	M	43 y	Rectum (Rec)	Adenocarcinoma	Malignant	T2N0M0	Well	3 Months	3x3 cm
1	E9	Human	M	43 y	Rectum (Rec)	Matched adjacent normal	Benign non-neoplastic
1	E10	Human	M	62 y	Rectum (Rec)	Adenocarcinoma, Tubular	Malignant	T2N1M0	Moderately		4x3x1.5 cm
1	E11	Human	M	62 y	Rectum (Rec)	Matched adjacent normal	Benign non-neoplastic
1	F1	Human	M	48 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N2M1	Poorly	1 Month	6x5x2 cm
1	F2	Human	M	47 y	Stomach (Sto)	Adenocarcinoma	Malignant	T3N2M0	Poorly-Moderately	30 Days	6x5x3 cm
1	F3	Human	F	42 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N3M0	Moderately	15 Days	4.2x4x2.2 cm
1	F4	Human	M	69 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N3M0	Moderately	1 Month	4.5x4x2.5 cm
1	F5	Human	M	40 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N2M0	Moderately	2 Months	3.6x3.5x2 cm
1	F6	Human	M	58 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N3M0	Poorly-Moderately	14 Days	4.7x4x2.1 cm
1	F7	Human	M	50 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N2M0	Poorly-Moderately	20 Days	4.5x3.5x1.5 cm
1	F8	Human	F	55 y	Stomach (Sto)	Adenocarcinoma	Malignant	T2N2M0	Moderately	1 Month	4x3x1.5 cm
1	F9	Human	F	55 y	Stomach (Sto)	Matched adjacent normal	Benign non-neoplastic
1	F10	Human	M	59 y	Stomach (Sto)	Adenocarcinoma	Malignant		Moderately-Well	1 Month	6x4.5x1.5 cm
1	F11	Human	M	59 y	Stomach (Sto)	Matched adjacent normal	Benign non-neoplastic

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.